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Introduction: Patients with clinical malaria have an increased risk for bacterial
bloodstream infections. We hypothesized that asymptomatic malaria parasitemia
increases susceptibility for bacterial infections through an effect on the innate immune
system. Wemeasured circulating cytokine levels and ex-vivo cytokine production capacity
in asymptomatic malaria and compared with controls.
Methods: Data were collected from asymptomatic participants <5 years old with and
without positive malaria microscopy, as well as from hospitalized patients <5 years old
with clinical malaria, bacteremia, or malaria/bacteremia co-infections in a malaria endemic
region of Burkina Faso. Circulating cytokines (TNF-a, IFN-g, IL-6, IL-10) were measured
using multiplex assays. Whole blood from asymptomatic participants with and without
positive malaria microscopy were ex-vivo stimulated with S. aureus, E. coli LPS and
Salmonella Typhimurium; cytokine concentrations (TNF-a, IFN-g, IL-1b, IL-6, IL-10) were
measured on supernatants using ELISA.
Results: Included were children with clinical malaria (n=118), bacteremia (n=22), malaria
and bacteremia co-infection (n=9), asymptomatic malaria (n=125), and asymptomatic
controls (n=237). Children with either clinical or asymptomatic malaria had higher plasma
cytokine concentrations than controls. Cytokine concentrations correlated positively with
malaria parasite density with the strongest correlation for IL-10 in both asymptomatic
(r=0.63) and clinical malaria (r=0.53). Patients with bacteremia had lower circulating IL-10,
TNF-a and IFN-g and higher IL-6 concentrations, compared to clinical malaria. Ex-vivo
whole blood cytokine production to LPS and S. aureus was significantly lower in
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asymptomatic malaria compared to controls. Whole blood IFN-g and IL-10 production in
response to Salmonella was also lower in asymptomatic malaria.
Interpretation: In children with asymptomatic malaria, cytokine responses upon ex-vivo
bacterial stimulation are downregulated. Further studies are needed to explore if the
suggested impaired innate immune response to bacterial pathogens also translates into
impaired control of pathogens such as Salmonella spp.
Keywords: asymptomatic malaria, bacteraemia, Salmonella, iNTS, bloodstream infection
INTRODUCTION
Plasmodium falciparum infections are a risk factor for bacterial
bloodstream infections (bBSI) (1, 2), especially those caused by
gram negative bacteria. Non-typhoidal Salmonellae are among the
most commonly found isolates in blood cultures among children in
sub-Saharan Africa (SSA) (3–5), both among patients with and
without co-occurring malaria infection. The case fatality rate of
invasive non-Typhoidal Salmonella (iNTS) bloodstream infection is
estimated at 20% (6). Patients with a co-infection malaria and iNTS
have an increased risk of mortality compared to patients with only
malaria or iNTS infection.
Pediatric iNTS and malaria overlap in terms of geographical
distribution, age distribution, and seasonality. Several studies
showed that a decreased malaria incidence in a particular region
was associated with a decreased iNTS incidence (7, 8). Different
mechanisms may underlie the epidemiologic association between
malaria and iNTS infections (9). First, the intestinal mucosal
barrier function is disturbed during malaria, facilitating invasion
and subsequently infection. Second, malaria is reported to cause
temporary neutrophil (10) and macrophage dysfunction, and
influences the cytokine production capacity of immune cells
which could alter susceptibility to iNTS (11). Third, changes in
iron homeostasis with increased storage of iron within
macrophages contributes to a suitable growing environment
for Salmonella infection (12).
So far, studies investigating the association between bBSI and
malaria are mostly limited to clinical malaria and animal models. In
many malaria-endemic areas, asymptomatic malaria parasitemia is
highly prevalent, but it is unknown whether asymptomatic malaria
increases the risk for bBSI by changes in the host immune responses
(9, 13). In the present study, we analyzed circulating cytokine
concentrations in asymptomatic healthy children below the age of
five with or without parasitemia and children with acute febrile
illness diagnosed with malaria, bBSI or co-infections. Furthermore,
we compared cytokine production capacity in asymptomatic
healthy children with or without parasitemia as an indicator of
the presence of immune tolerance.
METHODS
Study Site and Study Objectives
Samples were obtained from two studies conducted between
March 2016 and September 2017 at the Clinical Research Unit of
Nanoro (CRUN), a rural research facility situated in the central-
west region of Burkina Faso, at approximately 85km from the
capital city Ouagadougou (14). With an estimated 7.9 million
cases per year in 2017, Burkina Faso has one of the highest
incidences of malaria in SSA (15). Peak incidences coincide with
the rainy season (July-October), but cases occur year round.
Most cases are caused by Plasmodium falciparum, but
Plasmodium ovale and Plasmodium malariae are also
sporadically found (3, 16). Seasonal Malaria Chemoprophylaxis
(SMC) for children under 5 years was introduced in 2016.
The objective of this study was to assess the effect of
(asymptomatic) malaria on cytokine responses to bacterial
pathogens among children below the age of five, since children
of this age group are most likely to suffer from severe malaria and
iNTS infection. We hypothesized that patients with clinical
malaria and asymptomatic malaria have a lower cytokine
response to bacterial pathogens compared to patients who are
malaria microscopy slide negative. To assess our hypothesis, we
aggregated data from two studies simultaneously being carried
out at CRUN on respectively a healthy population
(ClinicalTrials.gov identifier: NCT03176719) and a population
presenting with acute febrile illness (AFI) (ClinicalTrials.gov
identifier: NCT02669823). For the current study, all
participants from either study who were less than 5 years old,
were selected.
The first study was an explorative cross-sectional study
among healthy volunteers of 1 year and older living in the
Health and Demographic Surveillance System (HDSS) area of
Nanoro. The HDSS area of Nanoro covers a population of
approximately 65.000 inhabitants distributed over 24 villages.
Study methods are described in detail elsewhere (Kaboré,
submitted; ClinicalTrials.gov identifier: NCT03176719). Briefly,
healthy participants of 1 year and older were randomly selected
from the 24 villages of the HDSS catchment area. Informed
consent was obtained from their parents or legal guardians. After
inclusion, an extensive electronic questionnaire concerning
health and demographic data was obtained. Finally, EDTA
anti-coagulated and heparinized blood was collected and
transported back to CRUN in a cool box for hemocytometry,
malaria diagnostics and ex-vivo whole blood stimulation.
Supernatants were stored at -80°C and shipped to the
Netherlands for cytokine analyses.
The second study was a phase-three diagnostic accuracy study
to assess the diagnostic performance of two novel technologies to
differentiate malaria, bacterial infections, and viral infections.
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Study methods are described in detail elsewhere (17). In summary,
participants of three months and older presenting with AFI at the
referral hospital of Nanoro were asked to participate in the study.
After consent was obtained basic clinical and demographic data
were registered. After inclusion, EDTA anti-coagulated blood and
an aerobic blood culture were obtained from each patient and
transported to the laboratory. Malaria diagnostics and blood
culture were performed on site. One milliliter whole-blood and
plasma samples were stored at -80°C and shipped to the
Netherlands for retrospective malaria- and bacterial PCRs, as
well as assessment of circulating cytokines.
Laboratory Procedures
Upon arrival at the clinical research laboratory of CRUN, the
EDTA blood samples were analyzed using an XN-1000
automated hematology analyzer (Sysmex Corporation, Kobe,
Japan). Complete blood counts (CBC) and leukocyte
differential were recorded.
Malaria Diagnostics
Thick and thin blood films were made using 10mL EDTA-
anticoagulated blood. Slides were stained with 3% Giemsa
solution and examined for presence of Plasmodium parasites
according to the World Health Organization (WHO) procedures
(18). Results were expressed as asexual parasites/µl using the
White Blood Cell (WBC) count as measured by hematology
analyzer. At least 200 white blood cells were counted. Slides were
viewed by two independent microscopists. In case of
discrepancies between the readers’ results (e.g. discrepancy
between positive and negative slides, a more than 1 log
difference in parasite density, or discrepancy in Plasmodium
species) the results of a third blinded microscopist was decisive.
Malaria diagnostics and hematology analysis were done within 6
hours after sample collection.
Ex-Vivo Whole Blood Stimulations
A heparinized whole blood sample was collected from
participants in the cross-sectional study for ex-vivo whole
blood stimulations. The whole blood stimulations were done at
the research laboratory of CRUN within 12 hours after blood
collection. Three stimuli (10ng/ml) Escherichia coli LPS
(serotype 055:B5, Sigma-Aldrich), 1x10ˆ6/ml heat killed
Staphylococcus aureus (clinical isolate) and 1x10ˆ6/ml heat-
killed Salmonella Typhimurium (ST-313 wildtype, obtained
from blood culture in the Democratic Republic of the Congo)
and a negative control medium (RPMI-1640 Dutch modification
(Life Technologies, Carlsbad, California, USA) supplemented
with gentamicin 50mg/ml, glutamax 2mM, pyruvate 1mM)
were used for each participant.
Blood was diluted at 1/5 in RPMI and distributed over four
wells per participant in a final concentration of 500 µl. Each well
was stimulated with one of four stimuli at an end concentration
of 1x106/ml and incubated at 37°C. After 48 hours, plates were
centrifuged at 400g for 5 minutes. Supernatant aliquots of 300 µl
were collected and stored in Micronics tubes (Lelystad, The
Netherlands) at -80°C. After completion of the trial, all
supernatants were transported to Radboudumc Nijmegen on
dry ice for batch analysis of cytokine levels. Participants with an
IL-1b and TNF-a response in the RPMI control sample were
considered contaminated and were therefore excluded
from analyses.
Cytokine Measurements in Supernatants
After Whole Blood Stimulation
Cytokines were assessed using commercial ELISA kits for human
TNF-a, IFN-g, IL-1b, IL-10 (R&D systems, MN, USA) and
human IL-6 (Sanquin, Amsterdam, the Netherlands) according
to manufacturer’s instructions. All assays were performed in a
timespan of two consecutive days: RPMI and Staphylococcus
aureus were measured on day one, Salmonella Typhimurium and
Escherichia coli LPS were measured on day two. Samples were
allowed to thaw at 4°C one day prior to analysis. Plate set-up was
randomized in terms of participant age, presence of
asymptomatic malaria and month of storage to decrease batch-
effect. Reported cytokine concentrations are based off standard
curves which were ran on each plate.
Circulating Cytokines Measurements
Circulating cytokines of patients participating to both studies
were batch-tested, using stored EDTA plasma samples. Plate set-
up was randomized as previously described. The pro-
inflammatory cytokines IL-6, TNF-a, IFN-g and anti-
inflammatory cytokine IL-10 were quantified using the
MAGPIX technology (Luminex Corporation, Austin, Texas,
USA) with the Human High Sensitivity Cytokine Premixed
Magnetic Luminex Performance Assay kits from Bio-Techne
(R&D systems). Manufacturer’s recommendations were followed
during the assay.
Case Definitions
Asymptomatic malaria was defined as one or more parasites in
thick smear malaria microscopy without fever or other acute
symptoms. Clinical malaria was defined as febrile patients with
one or more malaria parasites in thick smear microscopy and
without other possible explanations for the fever. Bacteremia was
defined as a blood culture grown with a pathogenic bacterium.
Combined malaria and bacteremia was recorded in case of
simultaneous blood culture grown with a pathogenic bacterium
and one or more malaria parasites in malaria thick smear
microscopy. Patients with a combined malaria and bacteremia
are hereafter referred to as “co-infection” or “Salmonella co-
infection” in case of combined malaria and Salmonella. Anemia
was defined by age and sex according to WHO classification.
Malnutrition was recorded as patients with a low weight-for-
height (wasting) or height-for-age (stunting) according to
WHO guidelines.
Statistical Analyses
As appropriate, means or medians were compared using a two-
sample t-test, Mann-Whitney U test or Kruskal-Wallis.
Differences in ex-vivo stimulated cytokine production between
participants with and without asymptomatic malaria were
corrected for using a multivariable regression, multicollinearity
was assessed using a correlation matrix. Data were log-
Post et al. Asymptomatic Malaria Downregulates Cytokine Levels in Ex-Vivo Stimulation
Frontiers in Immunology | www.frontiersin.org June 2021 | Volume 12 | Article 6148173
transformed for analysis in case of non-normal distribution. For
normally distributed cytokine measurements a linear regression
model was used. A Tobit regression was used for analyses with
results outside of the upper or lower quantification limits. The
association between cytokine production and parasite density
was measured using a Pearson’s correlation or Spearman’s
correlation as appropriate. Graphs and figures were created
using Graphpad (Graphpad Prism, version 7.00, La Jolla,
California, USA). A p-value of.05 was considered statistically
significant. Results were corrected for multiple testing using a
Bonferroni correction.
Ethical Considerations
Both study protocols were approved by the national health ethics
committee of Burkina Faso (ref 2016-01-006 and 2015-01-006
respectively). The diagnostic accuracy study was furthermore
approved by the internal review board of IRSS (ref A03-2016/
CEIRES) the ethical committee of the Antwerp University
Hospital (ref 15/47/492) and the institutional review board of
the Institute of Tropical Medicine Antwerp (ref 1029/15).
RESULTS
Baseline Characteristics
A total of 510 participants were included in this study: 361 from
the cross-sectional study among healthy participants, and 149
from the clinical diagnostic accuracy study (Figure 1).
The cross-sectional study enrolled 1000 participants between
June and October 2016, of whom 449 (44.6%) had asymptomatic
malaria. Out of 399 eligible participants, a total of 361 (90.5%)
participants were included in analysis; reasons for exclusion were
missing malaria microscopy data (n=33), missing demographic
data (n=2) and missing supernatant samples (n=3). Among
included participants, 125 (34.6%) had asymptomatic malaria.
The diagnostic accuracy study enrolled 930 patients between
March 2015 and July 2016, of whom 461 (49.6%) were between
three months and five years old. In total 171 of them were eligible
for inclusion in the current study: 171 patients had clinical
malaria, 30 patients had bacteremia (Salmonella spp n=18,
streptococci n=5, Escherichia coli n=3, Haemophilus influenzae
n=2, Neisseria meningitidis n=1 and one double infection) and 9
patients had a co-infection (Salmonella spp. n=6, and one of each
Streptococcus pneumoniae, Neisseria meningitidis and
Acinetobacter baumannii). Residual blood was available from
149/171 (87.1%) patients; n=118 (69.0%) with clinical malaria,
n=22 (73.3%) with bacteremia and n=9 (69.2%) with a
co-infection.
Baseline characteristics are presented in Table 1. Among
participants from the cross-sectional study, baseline
characteristics between participants with asymptomatic malaria
and slide negative participants were mostly similar. The number
of males was slightly higher among participants with
asymptomatic malaria, and participants with asymptomatic
malaria had a significantly higher monocyte count (1.1x103
cells versus 0.9x103 cells; p<.0001, lower Hb (10.3 g/dL versus
FIGURE 1 | Baseline characteristics of participants included in the current study; derived from participants to the diagnostic accuracy study among febrile patients
and the cross-sectional study on healthy participants.
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TABLE 1 | Baseline characteristics.
Cross sectional study Diagnostic accuracy study
Slide negative participants Asymptomatic Malaria Patients with clinical malaria Patients with Bacteremia* Combined malaria and bacteremia**
n=236 n=125 p-value n=114 n=22 n=9 p-value
Male sex (%) 116 (49.4%) 63 (50.0%) 69 (60.5%) 11 (50.0%) 4 (44.4%)
Age (months) 25.0 (21.9–41.1) 26.4 (23.3–39.6) .3 23.4 (13.7-36.5) 16.2 (11.7-26.7) 25.3 (23.6-36.9) .09
Weight (kg) 11.2 (10.0–12.6) 11.4 (10.0–12.9) .3 9.4 (8.1-11.3) 8.2 (7.0-10.2) 10.6 (9.2-11.2) .09
Height (cm) 83 (78–90.5) 83 (78–92) .9 81 (74-90) 77 (70-85) 82 (80-91) .3
Height for age (Z-score) -1.9 (-2.7/-1.2) -2.1 (-3.2/-1.2) .9 -1.3 (-2.3/-0.4) -1.4 (-1.9/0.4) -1.8 (-2.4/-1.3) .4
MUAC (cm) 15.2 (1.2) 15.3 (1.1) .2 NA NA NA
Axillary temperature (°C) 36.5 (36.1-37.1) 36.5 (36.1-36.9) .8 38.7 (38.0-39.8) 38.5 (38.0-39.4) 39.0 (38.8-39.8) .4
Days of fever NA NA 2.4 (1.0) 2.8 (1.4) 1.9 (0.6) .09
Pulse (/min) NA NA 125 (118-136) 130 (109-141) 114 (100-146) .8
Systolic pressure (mm/Hg) NA NA 97 (87-105) 95 (86-101) 98 (96-118) .2
Diastolic pressure (mm/Hg) NA NA 61 (53-65) 61 (51-63) 62 (56-62) .9
Breathing frequency (/min) NA NA 34 (32-41) 38 (32-42) 35 (33-36) .3
Impaired consciousness NA NA 17 (14.4%) 1 (4.6%) 1 (11.1%) .4
Hemoglobin (g/dl) 10.3 (1.4) 9.5 (1.7) <.0001 7.2 (2.5) 7.2 (2.3) 6.3 (1.9) .5
Reticulocytes 7.6 (5.5) 10.8 (7.2) <.0001 11.2 (8.0) 5.4 (4.1) 7.9 (3.6) .0009
Platelets (103/µl) 382 (159) 263 (144) <.0001 173 (108) 256 (199) 153 (97) .1
Leukocyte count (103/µl) 9.9 (3.2) 10.2 (3.1) .07 11.6 (9.1-18.2) 11.9 (10.4-15.2) 9.3 (5.8-20.2) .6
Monocyte count (103/µl) 0.9 (0.4) 1.1 (0.5) <.0001 1.1 (0.6-1.9) 0.9 (0.7-1.4) 0.7 (0.5-2.1) .6
Neutrophil count (103/µl) 3.0 (1.65) 2.8 (1.9) .07 6.0 (4.2-7.9) 5.5 (3.5-8.4) 6.1 (2.2-9.0) .8
Lymphocyte count (103/µl) 5.4 (2.0) 4.9 (2.2) .2 4.5 (2.6-6.9) 5.3 (3.6-6.9) 3.9 (1.7-9.0) .6
MUAC, Mid-upper arm circumference | * Salmonella (n=13), Escherichia coli (n=2), Haemophilus influenzae (n=2), Streptococci (n=4), Neisseria meningitidis (n=1) | ** Salmonella spp (n=6), Acinetobacter baumannii (n=1), Streptococcus
pneumoniae (n=1), Neisseria meningitidis (n=1) | *** Calculated using chi2 |.
Data is presented as mean (SD) in case of normally distributed data and median (25-75 IQR) in case of not normally distributed data. Significance value calculated using chi-2 for binary values, Mann-Whitney U-test in case of not normally distributed
and student’s t-test in case of normally distributed values. A Kruskal-Wallis test was done for continuous dependent variables in the diagnostic accuracy study. Parameters with a p-value of 0.1 or less were considered potential confounders.












































9.5 g/dL; p<.0001), Reticulocyte count (7.6 versus 10.8; p<.0001)
and lower platelet count (382 x103 cells versus 263 x103 cells;
p<.0001) compared to slide negative participants, but we found
no significant difference in age, height, weight, middle upper arm
circumference (MUAC), axillary temperature, white blood cell
count or neutrophil count between both groups.
Among participants in the diagnostic accuracy study, differences
between patients with clinical malaria, bacteremia and co-infection
were more pronounced, though this was also more difficult to
interpret due the variability in numbers of cases. Patients with
bacteremia were in median less than 1.5 years old, whereas patients
with malaria and those with co-infection were approximately 2
years old. The height-for-age among patients with co-infection was
considerably lower compared to patients with malaria and patients
with bacteremia, suggesting a correlation with chronic malnutrition.
Patients with co-infection typically presented at the hospital earlier
(1.9 day after onset of fever) compared to patients with clinical
malaria (mean 2.4 days) and bacteremia (mean 2.8 days) and had a
slightly higher temperature at presentation. As expected, patients
from the diagnostic accuracy study had higher neutrophil counts
compared to participants to the cross-sectional study. The median
numbers of white blood cells were comparable between
both groups.
Circulating Cytokines and Correlation to
Parasite Density
We first assessed circulating cytokine (IL-6, IL-10, TNF-a,
IFN-3g) concentrations among healthy participants with- and
without asymptomatic malaria and patients with clinical malaria.
All cytokines were highest among patients with clinical malaria
(Table 2) (19, 20) Participants with asymptomatic malaria also
had significantly higher circulating cytokines compared to
healthy participants without asymptomatic malaria. The
median parasite density among patients with clinical malaria
was 50,882 parasites/µL (IQR 7,587-104,497) compared to 3,517
parasites/µL (IQR 745-19,282) among participants with
asymptomatic malaria (p<.0001). Circulating cytokine
concentrations and parasite density significantly correlated for
both asymptomatic and clinical malaria (Figure 2). The
correlation was strongest for IL 10 (r=0.63 p>.0001 and r=0.53,
p<.0001 respectively), followed by IL6 (r=0.59, p<.0001) in
asymptomatic malaria, and TNF-a in clinical malaria (r=0.48,
p<0.001). The ratio between IL-10 levels and parasite density was
0.008 and 0.01 for clinical and asymptomatic malaria
respectively, whereas for IL-6 the ratio was 0.0014 versus
0.00088, and for TNF-a 0.0014 versus 0.010.
These results indicate that apart from IFN-g, all other tested
cytokine concentrations are upregulated in asymptomatic
malaria, as in clinical malaria. Cytokine concentrations were
significantly higher in clinical malaria, whereas the IL-10 and
TNF-a over parasi te density rat io were higher in
asymptomatic malaria.
We next assessed circulating cytokine concentrations in acute
febrile patients below the age of five diagnosed as malaria,
bacteremia, or malarial bacteremia co-infection. Results are
presented in Table 3 and Figure 3. Patients with bacteremia
had significantly lower IL-10 concentrations (p=0.02) compared
to those with malaria parasitemia with or without bacteremia co-
infection. The other circulating cytokines were not statistically
different between groups.
Further analysis of the different pathogens involved in
bacteremia (i.e. Gram positive [Streptococcus pneumoniae,
other Streptococci], Gram negative [Escherichia coli,
Haemophilus influenzae, Neisseria meningitidis], Salmonella
spp.) showed a lower IL-6 concentration among patients with
Salmonella bacteremia compared to the patients suffering from
infections with other pathogens. Patients with Salmonella
bacteremia also had the lowest circulating concentrations of
IL-10, but the highest concentration of IFN-g. There was no
significant correlation between parasite density and cytokine
levels among patients with co-infection, or Salmonella co-
infection. These results suggest that the anti-inflammatory
response (IL-10) is upregulated during clinical malaria
infections while pro-inflammatory IL-6 (and TNF-a) are
particularly downregulated during Salmonella bacteremia.
Ex-vivo Cytokine Production in
Participants With Asymptomatic Malaria
Versus Slide Negative Controls
To explore whether circulating immune cells of asymptomatic
patients with or without malaria parasitemia differed in their
capacity to produce cytokines, whole blood was stimulated with
various antigens, including heat killed Staphylococcus aureus
(S. aureus), heat-killed Salmonella Typhimurium and
Escherichia coli LPS (LPS). Samples from 180 (49.7%)
participants were excluded due to contamination of the sample
during the stimulation assay. The excluded participants are
further detailed in Supplementary Tables 1 and 2: there was
TABLE 2 | Circulating cytokine concentrations among malaria slide negative participants, participants with asymptomatic malaria and patient with clinical malaria.
Slide negative participants Asymptomatic malaria Patients withclinical malaria p-value Dunn’s test
n=235 n=126 n=118 SN versus AM SN versus CM AM versus CM
IL-6 1.2 (0.7-2.4) 3.4 (2.1-12.2) 69.2 (22.2-303.0) <.0001 <.0001 <.0001 <.0001
IL-10 3.8 (2.4-7.7) 56.2 (29.3-132.0) 439.0 (140.0-1,333.0) <.0001 <.0001 <.0001 <.0001
TNF-a 25.28 (20.2-30.6) 39.57 (30.6-53.5) 71.6 (42.5-121.0) <.0001 <.0001 <.0001 <.0001
IFN-y 2.1 (2.1-2.1) 2.1 (2.1-6.8) 42.9 (25.1-78.1) <.0001 .006 <.0001 <.0001
SN, slide negative; AM, asymptomatic malaria; CM, clinical malaria.
Data is presented as median (25-75 IQR). Significance value calculated using a Kruskal Wallis test with post-hoc Dunn’s test. Cytokine concentrations are reported in pg/mL.
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no significant difference in number of participants with
asymptomatic malaria between included and excluded samples
(n=67 versus n=59, respectively p=.38).
Table 4 and Figure 4 present the cytokine concentrations of
asymptomatic children with or without malaria parasitemia after
whole-blood stimulation with S. aureus, Salmonella
Typhimurium and LPS, after correction for age, sex, weight,
MUAC, leukocyte count, monocyte count, platelet count,
hemoglobin levels and ELISA-plate layout to correct for
batch effect. Height caused multicollinearity and was therefore
not corrected for.
Significantly lower cytokine responses (IL-1b, IL-6, IL-10,
TNF-a and IFN-g) to LPS and Staphylococcus aureus were
observed among participants with asymptomatic malaria
compared to controls. Participants with asymptomatic malaria
had also lower IFN-g and IL-10 responses after Salmonella
Typhimurium stimulation, while monocyte cytokines (IL-1b,
IL-6, TNF-a) were not statistically different between slide
FIGURE 2 | Correlation between parasite density and concentrations of various circulating cytokines in asymptomatic malaria and clinical malaria, among patients
below the age of five. Legend | parasite densities reported in parasites/µL. Cytokine concentrations are reported in pg/mL.
FIGURE 3 | Circulating cytokine concentrations among patients below five years old with blood culture confirmed bacteremia (Gram positive, Gram negative,
Salmonella) and malaria-bacteremia co-infection. Legend | Cytokine concentrations reported in pg/mL.
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negative participants and participants with asymptomatic
malaria. Likewise, we found that cytokine responses to
Salmonella Typhimurium were generally considerably higher
compared to the other two stimuli.
In the whole-blood stimulations, parasite density was strongly
negatively correlated to production of most cytokines (Figure 5).
IL-6, IL-10 and IL-1b in samples exposed to Salmonella
Typhimurium did not significantly correlate with parasite
densities, which corresponds to the ex-vivo cytokine
stimulation results.
These results suggest that asymptomatic malaria
downregulates the cytokine production capacity of circulating
immune cells after stimulation with LPS and heat killed S.
aureus, while Salmonella Typhimurium downregulates the
mostly lymphocyte-derived IFN-g but had limited effect on
monocyte-derived cytokines.
FIGURE 4 | Cytokine concentrations measured in supernatants after whole blood stimulation with Staphylococcus aureus, Salmonella Typhimurium (STM) and
Escherichia coli LPS (LPS), comparing participants with asymptomatic Malaria with thick film negative healthy controls. Legend | Cytokine concentrations reported in
pg/mL. For comparison, cytokine concentrations were log-converted. P-values corrected for multiple testing using a Bonferroni test.
TABLE 3 | Circulating cytokines among patients with clinical malaria, bacteremia, and combined malaria-bacteremia infection.
(n) IFN-g TNF-a IL-6 IL-10
Clinical malaria 114 42.9 (25.1-78.1) 71.6 (42.5-121.0) 69.2 (22.2-303.0) 439.0 (140.0-1,333.0)
Bacteremia 22 36.2 (11.3-205.0) 52.4 (27.4-71.11) 124.0 (21.3-457.0) 22.2 (8.9-100.0)
Co-infection 9 83.7 (33.6-212.0) 85.6 (67.7-107.0) 64.7 (40.2-242.0) 333.0 (85.5-707.0)
p-value 0.2 0.1 .5 <.0001
Circulating cytokines differentiated by cause of bacteremia
Gram positive bacteremia 4 14.9 (9.7-25.0) 47.6 (22.7-72.4) 227.5 (124-540) 13.5 (11.9-38.6)
Gram negative bacteremia 5 14.6 (4.6-20.1) 62.6 (582-77.0) 457 (373.0-4617.0) 29.5 (5.6-174.0)
Salmonella bacteremia 13 45.2 (27.4-70.4) 30.6 (8.9-100.0) 14.6 (4.6-20.1) 25.6 (17.6-146.0)
Salmonella co-infection 6 148.4 (69.6-396.0) 92.8 (71.2-107.0) 49.2 (38.4-193.0) 104.8 (17.1-333.0)
Data is presented as median (25-75 IQR). Significance was calculated using Kruskal Wallis test. Cytokine concentrations are reported in pg/mL.
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DISCUSSION
Our findings demonstrate that plasma cytokine concentrations and
cytokine production capacity of circulating immune cells upon ex-
vivo bacterial stimulation in children with asymptomatic malaria are
altered compared to children without asymptomatic malaria.
Further studies should be done to explore whether the observed
downregulation of pro-inflammatory cytokines impairs the control
of bacterial infections, in particular intracellular infections such as
invasive Salmonella, confirming the non-benign nature of chronic
malaria parasitemia (21, 22).
The study has several strengths and weaknesses. A large
number of clinical cases and asymptomatic participants with
or without microscopic malaria were included, allowing for
comparison of different clinical phenotypes among individuals
living in a highly endemic malaria area. A limitation is the
number of samples that had to be excluded from ex-vivo cytokine
production analyses due to possible contamination. The large
number of contaminated cases may be explained by traces op
endotoxin in heparinized collecting tubes (23) or blood sampling
procedures during the field studies. The effect of excluding these
samples on our data was minimal; all analyses were performed
while including and excluding these isolates and results were not
significantly different, but it is possible that the high number of
excluded samples introduced a bias.
The study was carried out in a high malaria endemic area
which is both a strength - high number of asymptomatic cases,
and a weakness - submicroscopic malaria cases are likely to have
been included in the “slide negative” group. The number of these
sub-microscopic cases may be significant, as there is evidence of
missing on average half of all P. falciparum infections with
microscopy in endemic areas compared with PCR (24). On the
other hand, excluding the submicroscopic malaria cases is likely
to increase the observed differences in cytokine production
capacity between asymptomatic malaria and PCR negative
asymptomatic cases. A comparison with clinical cases would
have been interesting, however ex-vivo stimulation was not done
in symptomatic cases.
The introduction of seasonal malaria prophylaxis in 2016
(during our study period) may have influenced results, seeing as
part of the clinical malaria samples were collected prior to the
introduction of seasonal prophylaxis whereas the asymptomatic
cases were collected after introduction.
The amount of blood sampled was too low to perform all
analyses in duplicate. Since anemia is common among children
in the study site, to sample more blood would have been
unethical. However, the fact that we did not use duplicate
measurements may have introduced a bias.
The Salmonella serotype used in the stimulation experiments
was obtained from DR Congo (4) and not from the study site.
However, the strain is the same invasive clade (ST-313 Lineage
II) which is also most common in Burkina Faso (25) and is
therefore representative for the wild types prevalent at our study
site. For the detection of invasive Salmonella infections, blood
cultures were used in the clinical cases, which only have an
approximate sensitivity of 50% (26).
Several of our findings are in line with existing literature. Parasite
densities among patients with clinical malaria were significantly
higher compared to those with asymptomatic malaria. Likewise,
patients with clinical malaria infection had significantly higher
TABLE 4 | Multivariable regression analyses of whole blood stimulated samples among slide negative participants and participants with asymptomatic malaria.
Slide negative cases Asymptomatic malaria Coëfficiënt 95% CI t-statistic p-value
n=123 n=59
Staphylococcus aureus
Median 25-75 IQR Median 25-75 IQR Coëfficiënt 95% CI t-statistic p-value
IFN-g 56.3 39-157.9 39 39-39 -0.49 -0.84 - -0.15 -2.81 .03
TNF-a 3,950.4 2,460.5-5,811.3 1,710.4 505.4-3,269.0 -0.95 -1.33 - -0.56 -4.86 <.0001
IL-1b 927.3 562.3-1,362 404.1 185.4-792.1 -0.76 -1.07 - -0.44 -1.07 <.0001
IL-6 18,851.6 13,024.2-29,192.5 12,917.9 5,298.5-21,583.2 -0.65 -1.01 - -0.29 -3.57 <.0001
IL-10 575.3 353.4-887.5 432.4 299.4-849.2 -0.33 -0.60 - -0.05 -2.33 .01
Salmonella Typhimurium
Median 25-75 IQR Median 25-75 IQR Coëfficiënt 95% CI t-statistic p-value
IFN-g 115.1 40.8-318.7 23.3 19.5-112.9 -0.99 -1.62 - -0.37 -3.12 .01*a
TNF-a 4,205.7 2,767.2-6,457.8 5,332.8 2,593.4-8760.2 -0.05 -0.35 – 0.26 -0.30 .8
IL-1b 3,816.3 2,718.2-4,712.0 3,492.1 1,558.7-4,873.9 -0.09 -0.30 – 0.12 -0.86 .4*b
IL-6 35,579.3 25,873.2-55,766.3 42,766.3 27,196.0-60,000.0 -0.01 -0.22 – 0.20 -0.08 .9*c
IL-10 5,854.4 3,910.6-9,032.8 4,220.2 2,659.2-6,955.4 -0.64 -1.10 - -1.8 -2.75 .04
LPS
Median 25-75 IQR Median 25-75 IQR Coëfficiënt 95% CI t-statistic p-value
IFN-g 51.3 20.9-201.2 19.5 19.5-76.3 -1.10 -1.76 - -0.45 -3.32 .005*d
TNF-a 3,750.7 2,442.0-5,843.4 2,859.1 574.9-4,933.3 -0.67 -1.08 - -0.27 -3.28 .005
IL-1b 1,468.5 945.1-2,138.1 908.8 277.5-2,164.8 -0.53 -0.88 - 09.19 -3.08 .01
IL-6 23,390.8 18,768.9-33,449.6 23,569.1 11,374.7-34,652.3 -0.45 -0.73 - -0.17 -3.17 .01
IL-10 4,727.5 3,314.7-6,845.3 2,252.2 1,075.9-4,718.9 -0.62 -0.91 - -0.34 <.0001
*Tobit regression; *a41 observations censored, *b5 observations censored, *c44 observations censored, *d57 observations censored.
Each cytokine was analyzed in a separate model. All models were corrected for age, sex, weight, MUAC, leukocyte count, monocyte count, platelet count, hemoglobin levels and ELISA-
plate layout to correct for batch effect. Cytokine concentrations are reported in pg/mL. For comparison, cytokine concentrations were log-converted. P-values corrected for multiple testing
using a Bonferroni test.
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circulating cytokine concentrations compared to participants with
asymptomatic malaria. We found a significant positive relation
between parasite densities and circulating cytokine levels (IL-10),
both in asymptomatic (27) and clinical malaria cases (28, 29).
Patients with combined malaria-bacteremia generally had the
highest circulating cytokine concentrations compared to patients
with malaria or bacteremia alone. Among these patients, cytokine
concentrations did not statistically correlate with parasite density,
juxtaposed to all other analyses in which cytokine concentrations
either positively or negatively correlated to parasite density.
Together, these results suggest that once co-infection is
established, bacteremia is the primary determinant of cytokine
concentrations, and the downregulatory effect of malaria is no
longer clinically relevant.
FIGURE 5 | Correlations between parasite density and various cytokine levels measured in supernatants after whole blood stimulation with Staphylococcus aureus,
Salmonella Typhimurium (STM) and Escherichia coli LPS (LPS) among participants with asymptomatic malaria.
Post et al. Asymptomatic Malaria Downregulates Cytokine Levels in Ex-Vivo Stimulation
Frontiers in Immunology | www.frontiersin.org June 2021 | Volume 12 | Article 61481710
Comparing circulating cytokine concentrations among
asymptomatic participants, we also found significantly higher
pro- and anti-inflammatory cytokine concentrations in malaria
microscopy positive participants compared to microscopy
negative controls (30). The largest difference was found for IL-
10, confirming the presence and importance of an anti-
inflammatory response in asymptomatic malaria to dampen
the pro-inflammatory response and prevent the development
of clinical disease (31, 32). The cytokine/parasite density ratios
also pointed in this direction as the IL-10/parasite density ratio
was highest in asymptomatic malaria cases while the pro-
inflammatory IL-6/parasite density ratio was highest in
patients with clinical malaria. Previous studies demonstrate
that high levels of IL-6 as well as TNF-a contribute to
complications of malaria such as cerebral malaria (20).
Cytokine concentrations in the supernatant of stimulated
whole blood of asymptomatic participants indicate a
downregulation of cytokine production capacity of immune
cells in asymptomatic participants with positive malaria
microscopy compared to those with negative microscopy,
consistent with the hypothesis that Plasmodium induces
immune hyporesponsivity to bacterial antigenic stimulation.
Metenou et al (33) studying filarial infected patients with and
without asymptomatic malaria also found evidence using flow
cytometry of a lower cytokine production capacity of immune
cells in case of concurrent malaria parasitemia. Other previous
research focused on clinical malaria, demonstrating that
circulating blood samples of clinical malaria patients produced
a lower cytokine response (34–36) and contained less TNF-a and
IL-6 producing monocytes compared to healthy controls upon
stimulation with E. coli LPS (37). These cytokines play a crucial
role in host defense and an impaired cytokine production
capacity may therefore contribute to the clinically observed
increased susceptibility to bBSI in asymptomatic malaria (34,
37), an effect we found to be inversely related to parasite density.
While the current study also found a downregulation in cytokine
responses, it is difficult to interpret how this would affect clinical
outcome without a clinical study. On one hand a downregulation
of the early pro-inflammatory cytokines could impair the host
response leading to an increased susceptibility to bacterial
infections. Alternatively, the lower cytokine concentrations
could be sufficient to contain bacterial infection but prevent
further damage due to septicemia.
Specific cytokines are known to play a crucial role in the host
defense against intracellular pathogens like Salmonella. The early
immune response to Salmonella is driven by TNF-a, with the
purpose to contain a localized infection (9, 37). IFN-g, produced by
antigen-specific helper T cells, activates macrophages thereby
inducing intracellular killing mechanisms against Salmonella (38–
40). Simultaneously, Salmonella upregulates the IL-10 production of
monocytes, compromising the production of reactive oxygen
radicals and intracellular killing capacity of monocytes (41, 42).
The relatively low level of IL-6 among patients with iNTS as
observed in this study may partially explain why patients with
iNTS often present with relatively mild symptoms, as IL-6, together
with IL-1 are considered the major endogenous pyrogens (43, 44).
Numerous studies explored the effect of malaria on immune
cells, among others the effect of the malaria pigment hemozoin
(45). Hemozoin causes release of peroxidation derivatives in
mononuclear cells thereby impairing various functions of these
cells (46). Hemozoin is detected in mononuclear cells of clinical
and asymptomatic malaria cases reflecting the level of
parasitemia (47). Mononuclear cells are of special importance
to Salmonella as it invades and survives within these cells. It is
therefore remarkable that that stimulation with Salmonella
Typhimurium among participants with asymptomatic malaria
resulted in less IFN-g and IL-10 production compared to LPS
and S. aureus, while no significant difference was observed
among TNF-a, IL-1b and IL-6 production capacity. The latter
cytokines are primarily produced by monocyte/macrophages
while T cells mostly produce IFN-g. It must be noted that we
did not assess which cells were responsible for cytokine
production in the ex-vivo experiments and we can therefore
not rule out that T-cells may have contributed to the cytokine
concentrations in supernatants. Our findings suggest that the
downregulation of the IFN-g axis contributes to the increased
risk for iNTS among patients with asymptomatic malaria. The
importance of the IFN-g axis was also observed in other studies
assessing genetic risk profile for iNTS (48). A previous study (37)
suggests an important role for TNF-a as a risk factor for iNTS in
malaria. That study was however done using E. coli LPS instead
of heat-killed Salmonella, which may account for the difference
in results.
CLINICAL IMPLICATIONS
Asymptomatic malaria is common in sub-Saharan Africa, with a
reported prevalence up to 75% (13). Asymptomatic malaria has
long been associated with immunity against malaria while its
possible negative consequences are only more recently
recognized (21, 22). The observed increase in circulating
cytokine concentrations among patients with asymptomatic
malaria supports the presence of a pro-inflammatory state with
possible consequences on erythropoiesis and decreased
hemoglobin levels. Our present data demonstrate that
asymptomatic malaria modulates cytokine production capacity
of immune cells in response to stimulation with bacterial
pathogens that are common in SSA, which may influence the
early immune response to bacterial pathogens. A next step in
proving this theory may be to compare ex-vivo cytokine
concentrations among patients with asymptomatic malaria
before and after treatment for malaria. Conversely, the
presence of bacteremia may also affect asymptomatic malaria
infections: our findings of relatively low circulating levels of IL-
10 and IFN-g in patients with bacteremia indicate a
compromised host defense against malaria and thus a less
restricted malaria infection. Treatment of asymptomatic
malaria may therefore not only reduce the malaria reservoir
and malaria transmission, but also protect against the effects of
malaria parasitemia on the immune system.
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